Literature DB >> 10534487

Dosing angiotensin II blockers--beyond blood pressure.

H Peters, E Ritz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534487     DOI: 10.1093/ndt/14.11.2568

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  7 in total

1.  Blood pressure response to conventional and low-dose enalapril in chronic renal failure.

Authors:  Thomas Elung-Jensen; Jens Heisterberg; Anne-Lise Kamper; Jesper Sonne; Svend Strandgaard
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

2.  Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.

Authors:  Thomas Elung-Jensen; Jens Heisterberg; Jesper Sonne; Svend Strandgaard; Anne-Lise Kamper
Journal:  Eur J Clin Pharmacol       Date:  2005-03-11       Impact factor: 2.953

Review 3.  How high should an ACE inhibitor or angiotensin receptor blocker be dosed in patients with diabetic nephropathy?

Authors:  Marc S Weinberg; Nicholas Kaperonis; George L Bakris
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

Review 4.  The tissue renin-angiotensin-aldosterone system in diabetes mellitus.

Authors:  Donna S Hanes; Anita Nahar; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

Review 5.  Is proteinuria a plausible target of therapy?

Authors:  Dave C Y Chua; George L Bakris
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

6.  Type 2 diabetes: RENAAL and IDNT--the emergence of new treatment options.

Authors:  Domenic A Sica; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jan-Feb       Impact factor: 3.738

7.  The Losartan Intervention for Endpoint Reduction (LIFE) trial-have angiotensin-receptor blockers come of age?

Authors:  Domenic A Sica; Michael Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jul-Aug       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.